This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

287 result(s)

Ellipta inhaler products | GSKpro

27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.

Home | GSKpro

For UK healthcare professionals. Get access to patient resources including samples and demo devices, exclusive webinars and updates on the latest in respiratory and more.

Medicines management and optimisation

Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects

GSK Highlights from ATS 2020 | GSKpro

GSK Highlights from The American Thoracic Society (ATS) Congress 2020

Respiratory

Overview of COPD and severe asthma.

Oncology Expert Insights

Expert opinion on ovarian cancer treatment to support UK healthcare professionals

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

Therapy areas

GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.

Cost | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) price information to support UK healthcare professionals

Guidelines |Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)| GSKPro

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Safety Information | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Lung Function | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Home | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Dosing & Administration | Nucala (mepolizumab)

Nucala (mepolizumab) can be administered at home or in clinic. Read more about dosing and administration here.

Identifying Patients | Nucala (mepolizumab)

Understand how to identify which patients with severe asthma are suitable for treatment with Nucala (mepolizumab) as an add-on treatment.

Expert Perspectives | Nucala (mepolizumab)

See what the experts have to say about Nucala (mepolizumab).

Paediatric Patients | Nucala (mepolizumab)

See the data behind and safety profile of Nucala (mepolizumab) in paediatric patients with severe asthma.

Safety Information | Nucala (mepolizumab)

See the safety profile of Nucala (mepolizumab) in adults and adolescents.

Efficacy | Nucala (mepolizumab)

Read the clinical data about Nucala (mepolizumab).

Nucala (meplizumab) | Severe eosinophilic asthma

Learn more about Nucala (mepolizumab) as an add-on treatment for patients with severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older.

GSK support for healthcare professionals in response to COVID-19

Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.

Head-to-head data | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) head-to-head data to support UK healthcare professionals

Guidelines | Anoro▼ Ellipta (umeclidinium / vilanterol)

COPD guidelines information relevant to Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) information to support UK healthcare professionals

vs. LAMA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA head-to-head data to support UK healthcare professionals

vs. LAMA/LABA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA/LABA head-to-head data to support UK healthcare professionals

Anoro Patient | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) patient profile information intended to support UK healthcare professionals

Molecules | Anoro▼ Ellipta (umeclidinium / vilanterol)

Information about the molecules in Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

Video Testimonials: I've Seen Meningitis

Video testimonials from healthcare professionals about the impact of meningitis

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

Experts’ perspectives | Anoro▼ Ellipta (umeclidinium / vilanterol)

Experts' perspectives and patient case study videos relevant to the LAMA/LABA class to support UK healthcare professionals

Vaccines

GSK UK information about our vaccines and disease awareness campaigns

DECTOVA▼

Zanamivir IV</br> Influenza

ZEJULA▼

Niraparib<br>Oncology

Efficacy

Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.

Dose & Device | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) dosing and device information to support UK healthcare professionals

Contact | GSKpro UK

GSK UK contact page for healthcare professionals.

Coming soon | GSKpro

This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) I COPD I GSKPro

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

COPD expert perspectives

Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.

BLENREP▼

belantamab mafodotin<br> Oncology

BENLYSTA▼

belimumab<br> Musculoskeletal

Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Optimising Prescribing for COPD Patients; What Matters Most?| GSKpro

Registration page for a webinar on ‘Optimising Prescribing for COPD Patients’ for UK Health Professionals

FAQ | Supply | GSKpro

Frequently asked questions around the supply and availability of GSK medicines and vaccines.

GSK Highlights from ERS 2020 | GSKpro

GSK Highlights from European Respiratory Congress 2020

Resources | GSKpro

Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.

Zejula ▼ (niraparib)

Zejula ▼ (niraparib) product information for healthcare professionals detailing the top line efficacy, safety and dosing data

Safety | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Bexsero GSKpro Invasive meningococcal disease

Bexsero prescribing information for healthcare professionals

Dosing and administration | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Real world evidence | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Report a possible side effect | GSKpro

Information for UK healthcare professionals on how to report an adverse event related to a GSK product

Molecules | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Products | GSKpro

GSK product information for UK healthcare professionals

SHINGRIX▼

Herpes zoster vaccine recombinant, adjuvanted<br> Vaccines

Scientific Rationale | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Discontinued products | GSK Pro

Discontinued products

Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

PHN-Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

HRQoL | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Dosing & Device | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) dosing & device information to support UK healthcare professionals

Safety | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Cost | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Request a contact

Contact us form for UK healthcare professionals to contact GSK

Resources | Nucala (mepolizumab) | For Healthcare Professionals Only

View the resources available to support your patients prescribed Nucala (mepolizumab).

Identifying patients | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more